Using Del-1 to tip the angiogenic balance in endothelial cells in modular constructs

Tissue Engineering - Part A

Volumn 20, Issue 7-8, 2014, Pages 1222-1234

  Ciucurel, Ema C ^a,b   Vlahos, Alexander E ^b   Sefton, Michael V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL ADHESION; CELL ENGINEERING; ENDOTHELIAL CELLS; GENE EXPRESSION; TISSUE ENGINEERING;

EXTRACELLULAR MATRIX PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INTERCELLULAR ADHESION MOLECULE-1; MATRIX METALLOPROTEINASE-9; MESENCHYMAL STROMAL CELLS; TISSUE-ENGINEERED CONSTRUCTS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TISSUE;

ANGIOPOIETIN 2; ENHANCED GREEN FLUORESCENT PROTEIN; FIBRIN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; LENTIVIRUS VECTOR; UROKINASE; VASCULOTROPIN A; CARRIER PROTEIN; EDIL3 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERIOLE; ARTICLE; CAPILLARY; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DEVELOPMENTAL ENDOTHELIAL LOCUS 1; DOWN REGULATION; ENDOTHELIUM CELL; GEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LABORATORY DEVICE; MESENCHYMAL STROMA CELL; MICROCARRIER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULARIZATION; VENULE; ANIMAL; BIOASSAY; BLOOD VESSEL; BOVINAE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMPLANT; LENTIVIRINAE; METABOLISM; PROCEDURES; SCID MOUSE; TISSUE SCAFFOLD;

ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; BLOOD VESSELS; CARRIER PROTEINS; CATTLE; CELL PROLIFERATION; FIBRIN; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMPLANTS, EXPERIMENTAL; LENTIVIRUS; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC;

EID: 84898422657     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0241     Document Type: Article

References (51)

1. Hidai, C., Zupancic, T., Penta, K., Mikhail, A., Kawana, M., Quertermous, E.E., et al. Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the alpha vbeta 3 integrin receptor. Genes Dev 12, 21, 1998
2. Bornstein, P., and Sage, E.H. Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol 14, 608, 2002
3. Bornstein, P. Matricellular proteins: An overview. J Cell Commun Signal 3, 163, 2009
4. Zhong, J. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein del-1. J Clin Invest 112, 30, 2003
5. Ho, H.K., Jang, J.J., Kaji, S., Spektor, G., Fong, A., Yang, P., et al. Developmental endothelial locus-1 (del-1), a novel angiogenic protein: Its role in ischemia. Circulation 109, 1314, 2004
6. Fan, Y., Zhu, W., Yang, M., Zhu, Y., Shen, F., Hao, Q., et al. Del-1 gene transfer induces cerebral angiogenesis in mice. Brain Res 1219, 1, 2008
7. Kown, M.H., Suzuki, T., Koransky, M.L., Penta, K., Sakamoto, G., Jahncke, C.L., et al. Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia. Ann Thorac Surg 76, 1246, 2003
8. Wang, Z., Kundu, R.K., Longaker, M.T., Quertermous, T., and Yang, G.P. The angiogenic factor del1 prevents apoptosis of endothelial cells through integrin binding. Surgery 151, 296, 2012
9. Rezaee, M., Penta, K., and Quertermous, T. Del1 mediates vsmc adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3). Am J Physiol Heart Circ Physiol 282, H1924, 2002
10. Choi, E.Y., Chavakis, E., Czabanka, M.A., Langer, H.F., Fraemohs, L., Economopoulou, M., et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322, 1101, 2008
11. Eskan, M.A., Jotwani, R., Abe, T., Chmelar, J., Lim, J.H., Liang, S., et al. The leukocyte integrin antagonist del-1 inhibits il-17-mediated inflammatory bone loss. Nat Immunol 13, 465, 2012
12. Chavakis, E., Choi, E.Y., and Chavakis, T. Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost 102, 191, 2009
13. Choi, E.Y. Inhibition of leukocyte adhesion by developmental endothelial locus-1 (del-1). Immune Netw 9, 153, 2009
14. McGuigan, A.P., and Sefton, M.V. Vascularized organoid engineered by modular assembly enables blood perfusion. Proc Natl Acad Sci U S A 103, 11461, 2006
15. McGuigan, A.P., Leung, B., and Sefton, M.V. Fabrication of cell-containing gel modules to assemble modular tissueengineered constructs [corrected]. Nat Protoc 1, 2963, 2006
16. Cooper, T.P., and Sefton, M.V. Fibronectin coating of collagen modules increases in vivo huvec survival and vessel formation in scid mice. Acta Biomater 7, 1072, 2011
17. Butler, M.J., and Sefton, M.V. Cotransplantation of adipose-derived mesenchymal stromal cells and endothelial cells in a modular construct drives vascularization in scid/ bg mice. Tissue Eng Part A 18, 1628, 2012
18. Chamberlain, M.D., Gupta, R., and Sefton, M.V. Chimeric vessel tissue engineering driven by endothelialized modules in immunosuppressed sprague-dawley rats. Tissue Eng Part A 17, 151, 2011
19. Chamberlain, M.D., Gupta, R., and Sefton, M.V. Bone marrow-derived mesenchymal stromal cells enhance chimeric vessel development driven by endothelial cell-coated microtissues. Tissue Eng Part A 18, 285, 2012
20. Ciucurel, E.C., and Sefton, M.V. Del-1 overexpression in endothelial cells increases vascular density in tissue engineered implants containing endothelial cells and adiposederived mesenchymal stromal cells. Tissue Eng Part A; [DOI: 10.1089/ten.tea.2013.0242 Epub ahead of print]; PMID: 24151812, 2013
21. Dietrich, F., and Lelkes, P.I. Fine-Tuning of a threedimensional microcarrier-based angiogenesis assay for the analysis of endothelial- mesenchymal cell co-cultures in fibrin and collagen gels. Angiogenesis 9, 111, 2006
22. Nehls, V., and Drenckhahn, D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of threedimensional cell migration and angiogenesis. Microvasc Res 50, 311, 1995
23. Rieu, I., and Powers, S.J. Real-Time quantitative rt-pcr: Design, calculations, and statistics. Plant Cell 21, 1031, 2009
24. Kachgal, S., and Putnam, A.J. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14, 47, 2011
25. Ghajar, C.M., Kachgal, S., Kniazeva, E., Mori, H., Costes, S.V., George, S.C., et al. Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res 316, 813, 2010
26. Kroon, M.E., Koolwijk, P., van Goor, H., Weidle, U.H., Collen, A., van der Pluijm, G., et al. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 154, 1731, 1999
27. Binder, B.R., Mihaly, J., and Prager, G.W. Upar - upa - pai-1 interactions and signaling: A vascular biologist's view. Thromb Haemost 97, 336, 2007
28. van Hinsbergh, V.W., and Koolwijk, P. Endothelial sprouting and angiogenesis: Matrix metalloproteinases in the lead. Cardiovasc Res 78, 203, 2008
29. Ghajar, C.M., George, S.C., and Putnam, A.J. Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr 18, 251, 2008
30. Ferrara, N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25, 581, 2004
31. Ferrara, N. Vegf-A: A critical regulator of blood vessel growth. Eur Cytokine Netw 20, 158, 2009
32. Ho, Q.T., and Kuo, C.J. Vascular endothelial growth factor: Biology and therapeutic applications. Int J Biochem Cell Biol 39, 1349, 2007
33. Thomas, M., and Augustin, H.G. The role of the angiopoietins in vascular morphogenesis. Angiogenesis 12, 125, 2009
34. Lawson, C., and Wolf, S. Icam-1 signaling in endothelial cells. Pharmacol Rep 61, 22, 2009
35. Boudreau, N., Andrews, C., Srebrow, A., Ravanpay, A., and Cheresh, D.A. Induction of the angiogenic phenotype by hox d3. J Cell Biol 139, 257, 1997
36. McGuigan, A.P., and Sefton, M.V. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 28, 2547, 2007
37. She, M., McGuigan, A.P., and Sefton, M.V. Tissue factor and thrombomodulin expression on endothelial cell-seeded collagen modules for tissue engineering. J Biomed Mater Res A 80, 497, 2007
38. Schechner, J.S., Nath, A.K., Zheng, L., Kluger, M.S., Hughes, C.C., Sierra-Honigmann, M.R., et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A 97, 9191, 2000
39. Enis, D.R., Shepherd, B.R., Wang, Y., Qasim, A., Shanahan, C.M., Weissberg, P.L., et al. Induction, differentiation, and remodeling of blood vessels after transplantation of bcl-2-Transduced endothelial cells. Proc Natl Acad Sci U S A 102, 425, 2005
40. Cheng, G., Liao, S., Kit Wong, H., Lacorre, D.A., di Tomaso, E., Au, P., et al. Engineered blood vessel networks connect to host vasculature via wrapping-And-Tapping anastomosis. Blood 118, 4740, 2011
41. Jay, S.M., Shepherd, B.R., Andrejecsk, J.W., Kyriakides, T.R., Pober, J.S., and Saltzman, W.M. Dual delivery of vegf and mcp-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31, 3054, 2010
42. Jay, S.M., Shepherd, B.R., Bertram, J.P., Pober, J.S., and Saltzman, W.M. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J 22, 2949, 2008
43. Critser, P.J., Kreger, S.T., Voytik-Harbin, S.L., and Yoder, M.C. Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo. Microvasc Res 80, 23, 2010
44. Papayannakos, C., and Daniel, R. Understanding lentiviral vector chromatin targeting: Working to reduce insertional mutagenic potential for gene therapy. Gene Ther 20, 581, 2013
45. Persons, D.A. Lentiviral vector gene therapy: Effective and safe?. Mol Ther 18, 861, 2010
46. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24, 687, 2006
47. Hahn, W.C., and Weinberg, R.A. Rules for making human tumor cells. N Engl J Med 347, 1593, 2002
48. Somanath, P.R., Ciocea, A., and Byzova, T.V. Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys 53, 53, 2009
49. Smyth, S.S., and Patterson, C. Tiny dancers: The integringrowth factor nexus in angiogenic signaling. J Cell Biol 158, 17, 2002
50. Eliceiri, B.P. Integrin and growth factor receptor crosstalk. Circ Res 89, 1104, 2001
51. Mahabeleshwar, G.H., Feng, W., Reddy, K., Plow, E.F., and Byzova, T.V. Mechanisms of integrin-vascular endothelial growth factor receptor cross-Activation in angiogenesis. Circ Res 101, 570, 2007.